Review of 'Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series'

Reviewer: arnab kumar banerjee

Publication date of review: 2021-07-22

Bookmark

arnab kumar banerjee5

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesCrossref ScienceOpen

cases show a significant result

Average rating:	    Rated 5 of 5.
Level of importance:	    Rated 5 of 5.
Level of validity:	    Rated 5 of 5.
Level of completeness:	    Rated 5 of 5.
Level of comprehensibility:	    Rated 5 of 5.
Competing interests:	None

Reviewed article

Record: found
Abstract: not found
Article: not found

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William Werbel, Brian J. Boyarsky, Michael Ou … (2021)

0 comments Cited 192 times     Rated -3 of 5. – based on 1 reviews

Bookmark

Review information

Review text

one good news is that the antibodies are increased. but the limitation is hurting. b cell, t cell are important and antibody neutralization is also important. it is like you set a fire without knowing how to extinguish the fire. later these increased antibody may cause another different kind of trouble.

Review of 'Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series'

Reviewed article

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

Review information

Review text

Comments

Comment on this review